To further investigate whether TFAM expression is associated with the progression of NSCLC, the TFAM protein expression levels and the clinic pathologic characteristics of 150 NSCLC patients were analyzed by IHC. The gene discussed is TFAM; the disease is non-small cell lung carcinoma.